M+ Online
12th December 2022

Stock Digest - Supercomnet Technologies Bhd - Still Decent Despite Minor Hiccup

Despite the slower contribution from Ambu, growth from the medical segment will be anchored by new products coming onto stream in 2023. This include IHS nonelectric syringe infusion system that will see mass production coming onto stream in December 2022, Ambu’s Falcon–C (colonoscope) in 2QFY23 and Plass’ soldier first aid hemostatic product that is still awaiting for FDA approval.

View Document
Ready to start trading?

Open an Account with M+ Online and begin your investment journey today

Register Now
Recent Posts